Health ConditionsMucus is a clear, slippery, gel-like substance that is part of the immune system. It lines the mucous membranes and helps trap, destroy, or clear out germs and harmful particles. Mucus as a whole is essentially a water-based gel consisting of glycoproteins, immunoglobulins, lipids, and other substances. It is a viscous colloid containing inorganic salts, antimicrobial enzymes (such as lysozymes), immunoglobulins (especially IgA), and glycoproteins such as lactoferrin and mucins, which are produced by goblet cells in the mucous membranes and submucosal glands.
The word "phlegm" derives from the Ancient Greek φλÎγμα (phlégma), meaning "inflammation" or "humour caused by heat." In modern usage, the two terms carry distinct meanings: phlegm is typically restricted in its definition, referring to the mucus produced by the respiratory system specifically in response to inflammatory stimulation. Once phlegm is expectorated, it is referred to as sputum.
Mucus is a slippery fluid that lines the respiratory, digestive, urinary, and reproductive tracts. Most of the mucus in the body is produced in the gastrointestinal tract. However, in the context of natural health, attention is most commonly directed at the respiratory tract, where mucus is part of the airway surface liquid (ASL), also known as epithelial lining fluid, that lines most of the respiratory tract. The airway surface liquid consists of a sol layer termed the periciliary liquid layer and an overlying gel layer termed the mucus layer.
Mucus is secreted from two distinct areas within the lung tissue. In the surface epithelium — part of the tissue lining of the airways — there are mucus-producing cells called goblet cells. The connective tissue layer beneath the mucosal epithelium contains seromucous glands that also produce mucus. The respiratory tract produces about two litres of mucus a day from these glands. This is composed of water, carbohydrates, proteins, and lipids. The high water content helps to humidify the passing inspired air. Mucus contains glycoproteins (or mucins) as well as proteins derived from plasma and products of cell death such as DNA. Mucus is sticky, and this helps to trap dust particles, bacteria, and other inhaled debris.
In the human respiratory tract, MUC5AC and MUC5B are the predominant mucin subtypes. MUC5B is constantly expressed, whereas MUC5AC can be induced by pathogens, gases, inflammatory mediators, and adrenergic, cholinergic, and neurohumoral factors.
Mucus is produced continuously in the respiratory tract. Mucociliary action carries it down from the nasal passages and up from the rest of the tract to the pharynx, with most of it being swallowed subconsciously. Tiny hairs called cilia trap large pieces of debris and waft them out of the airways; the reflexes of sneezing and coughing help to expel particles from the respiratory system, and the production of mucus keeps the tissues moist and helps to trap small particles of foreign matter.
The composition of mucus varies depending on climate, genetics, and state of the immune system. Its colour can vary from transparent to pale or dark yellow and green, from light to dark brown, and even to dark grey depending on the contents. Mucus gets thick and sticky, and might be white, yellow, or green when there is an infection.
Mucus hypersecretion is a pathological condition characterised by excessive production and secretion of mucus in the airways. It plays a central role in many respiratory diseases, contributing to airway obstruction, impaired gas exchange, and recurrent infections.
Sometimes mucus is produced in excess and changes in nature. This results in the urge to cough and expectorate this mucus as sputum. Sputum expectoration is not normal, and there is always an underlying pathological cause.
Phlegm is often produced in response to inflammation and contains glycoprotein-based mucus alongside immunoglobulins, viruses, bacteria, and inflammatory cells. Airway mucus is a highly specialised secretory fluid that functions as a physical and immunological barrier to pathogens whilst lubricating the airways and humidifying atmospheric air. Dysfunction is common during illness and is characterised by changes in production rate, chemical composition, physical properties, and inflammatory phenotype.
In normal individuals, mucus is swept out of the respiratory system while coughing in the form of sputum or phlegm; but if the consistency of the mucus is thick, or the amount is heavy, or there is a defect in ciliary function, the mucus is not cleared and accumulates in the lungs. Mucus trapped in the distal airways cannot be cleared by coughing, forming a layer in the alveoli and bronchioles. Long-standing accumulation causes inflammation and infection.
Increased mucus secretion is seen in chronic disease states such as asthma, COPD, and chronic bronchitis; in genetic diseases such as cystic fibrosis; in allergic conditions (atopy, allergic inflammation); in bronchiectasis; and in a number of acute infectious respiratory illnesses such as pneumonia, rhinitis, influenza, or the common cold. Accompanying hypersecretion of mucus in many of these respiratory diseases is the constant presence of inflammatory cells in the airways, which contribute greatly to the pathology of these diseases via the tissue damage done by inflammatory mediators released from these cells.
The most common exogenous factor that stimulates mucus hypersecretion is cigarette smoke. Previous studies have shown that cigarette smoke extract can increase the expression of MUC5AC in a concentration-dependent manner. Another common risk factor is particulate matter 2.5 (PM2.5), which can be deposited in the small airways and induce MUC5AC expression caused by oxidative stress.
Research published in the American Journal of Physiology demonstrated that activation of epidermal growth factor receptors (EGFR) is responsible for mucin production after inhalation of cigarette smoke in airways in vitro and in vivo. In the airway epithelial cell line NCI-H292, exposure to cigarette smoke upregulated EGFR mRNA expression and induced activation of EGFR-specific tyrosine phosphorylation, resulting in upregulation of MUC5AC mRNA and protein production. Chronic airway inflammation, such as that occurring in COPD, induces goblet cell metaplasia and hyperplasia and leads to hyperproduction of mucus and thickening of airway walls. Cigarette smoke causes chronic inflammation and goblet cell metaplasia and hyperplasia in the airways through a complex mechanism involving various factors, including immune cells.
Several inflammatory mediators are responsible for stimulating mucus secretion and subsequent goblet cell hyperplasia. IL-13 is among the most potent cytokines, acting via the interleukin receptor IL-4Rα to activate transcription of MUC5AC and MUC5B. Other endogenous factors that induce mucus hypersecretion include neutrophil elastase, IL-1β, IL-4, lipopolysaccharide (LPS), and matrix metalloproteinase-9 (MMP-9).
Western dietary patterns, notably marked by an elevated intake of preserved and processed meats, are correlated with a heightened risk of chronic respiratory diseases. This correlation could be due to the inflammatory consequences of excessive sugar, salt, and nitrite consumption from processed foods.
In the lung, environmental triggers stimulate inflammatory and allergic reactions resulting in mucus hypersecretion, epithelial and tissue remodelling, and compromised lung function. This microenvironment change allows for microbial changes which increase the rate of respiratory infections in asthmatic patients. Both IBD and asthma pathogenesis is related to reduced microbiota-derived short-chain fatty acids (SCFAs), malabsorption of iron and vitamins, and reduced gut-derived SCFAs resulting in a trend toward an inflammatory immune response.
There is a widespread belief among some members of the public that the consumption of milk and dairy products increases the production of mucus in the respiratory system. Some who believe in this effect renounce drinking milk. The scientific evidence is nuanced. In individuals inoculated with the common cold virus, milk intake was not associated with increased nasal secretions, symptoms of cough, nose symptoms, or congestion. Nevertheless, individuals who believe in the mucus-and-milk theory report more respiratory symptoms after drinking milk.
A separate hypothesis focuses on a specific casein peptide: the hypothesis is that A1 milk increases mucus production in the respiratory tract in a sub-population of people who have increased intestinal permeability. Specifically, β-casomorphin-7 (β-CM-7) acts via μ-opioid receptors on goblet cells to upregulate MUC5AC gene expression and increase mucus secretion. This would occur only in specifically primed tissues and only when β-CM-7 was able to pass into the systemic circulation. This association may not necessarily be simply cause and effect, as the person has to be consuming A1 milk, β-CM-7 must pass into the systemic circulation, and the tissues have to be actively inflamed. These prerequisites could explain why only a subgroup of the population who have increased respiratory tract mucus production find that many of their symptoms improve on a dairy elimination diet. This hypothesis remains unconfirmed in large-scale human trials.
NAC is a modified form of the amino acid cysteine and has no substantial traditional ethnobotanical history; it was developed as a pharmaceutical mucolytic in the mid-twentieth century. Its widespread clinical use predates large-scale randomised trial data.
NAC is a key precursor of glutathione (GSH), the lung's principal antioxidant. First developed as a mucolytic, NAC is now recognised for broader antioxidant, anti-inflammatory, immunomodulatory, and anti-biofilm effects, prompting its use as an adjuvant in treatment of chronic respiratory conditions.
N-acetylcysteine, an effective mucolytic agent, not only reduces the viscosity and elasticity of sputum, but also has anti-inflammatory and antioxidant activity. Moreover, N-acetylcysteine has shown a protective effect against the detrimental impact of lipopolysaccharide in vitro. A large randomised placebo-controlled trial demonstrated that a high dose of oral N-acetylcysteine (1,200 mg/day) for one year significantly reduced the rate of exacerbations and improved quality of life in patients with chronic obstructive pulmonary disease (COPD).
A 2023 meta-analysis (PMC) included nine randomised controlled trials with over 2,000 COPD patients comparing NAC to placebo. An expert panel agreed that in the management of stable COPD, NAC is beneficial for prevention of acute exacerbations, owing to its mucolytic, anti-inflammatory, antioxidant, and anti-infective properties. However, the Global Initiative for Chronic Obstructive Lung Disease recognises that mucolytic and antioxidant drugs such as NAC can be used as adjunct therapy to reduce the risk of acute exacerbation of COPD, but in a limited way due to the lack of robust randomised controlled clinical trials.
NAC is a proven adjunctive therapy for COPD, bronchiectasis, and cystic fibrosis. While promising for tuberculosis and respiratory infections, further evidence is required. Its efficacy in asthma and interstitial lung diseases remains uncertain. Evidence is strongest for COPD and weakest for acute ventilated patients; data from at least one randomised controlled trial do not support routine use of NAC in mechanically ventilated patients, either as an antioxidant or as a mucolytic agent.
Thyme has been used in European folk medicine and official herbalism for centuries as an expectorant and antispasmodic for coughs and bronchitis. Ivy leaf has a similarly long history in Central European herbal practice as an expectorant for productive cough. Both herbs appear in the German Commission E monographs and in the guidelines of the German Respiratory Society.
A fixed combination of thyme herb and ivy leaf fluid extracts has been employed as a therapeutic agent for the treatment of cough associated with infections or inflammations of the lower respiratory tract for over two decades. In vitro and in vivo studies have shown that the active compounds manifest multiple anti-inflammatory effects, and clinical studies have demonstrated the efficacy of this thyme-ivy syrup in providing symptom relief and reducing recovery time in patients with acute bronchitis and cough.
Thyme is described as an antibacterial secretolytic, while ivy is classified as an antispasmodic expectorant. Both agents have anti-inflammatory and mucus-normalising properties. A large non-interventional, pharmacy-based, real-life study provides evidence for the effectiveness and tolerability of the thyme/ivy combination BNO 1200 in acute cough, supporting efficacy and a highly favourable risk–benefit ratio shown earlier in RCTs with similar herbal drug combinations.
As regards the efficiency of Hedera helix leaf extracts as an expectorant, the clinical data available are not conclusive. According to a review summarising data from 13 clinical trials, herbal preparations from H. helix could serve as a remedy for early symptoms of respiratory tract infections, regardless of age. However, another systematic review focused on the use of Hederae folium extracts for the treatment of acute upper respiratory tract infections confirmed their safety as cough medications, but regarding minimising cough severity and/or frequency, the clinical significance of the data seemed very poor.
A fixed combination of Thymus herba and Primulae radix extract reduced the Bronchitis Severity Score in acute bronchitis in both adults and children across multiple randomised trials. Overall evidence strength: Moderate for symptom reduction in acute bronchitis; individual studies are often open-label or have small sample sizes, and more rigorous placebo-controlled trials are needed.
Historically, turmeric has been used in Chinese, Indian (Ayurvedic), Islamic, and Thai traditional medicine systems for conditions such as indigestion, the common cold, skin infections, arthritis, abdominal pain, and liver disease. In Ayurveda, turmeric milk (sometimes called "golden milk") is a classical preparation used for respiratory complaints including cough and congestion.
Curcumin, a major component of turmeric, gives the spice its yellow colour. The health activities of turmeric are commonly attributed to curcuminoids, which include curcumin. Mechanistically, curcumin inhibits NF-κB signalling pathways that upregulate pro-inflammatory cytokines involved in mucus production. A 2025 comprehensive review examined evidence on omega-3 polyunsaturated fatty acids, vitamin D, curcumin, ginger bioactives, quercetin, and epigallocatechin gallate (EGCG) in allergy prevention and management using a search of PubMed, Scopus, and Web of Science up to July 2025. Current clinical evidence for curcumin specifically in mucus hypersecretion remains largely derived from preclinical and mechanistic studies; robust human RCTs targeting mucus specifically are limited. Poor oral bioavailability is a widely acknowledged limitation of standard curcumin preparations.
Quercetin is a polyphenolic flavonoid found naturally in apples, onions, capers, and leafy green vegetables. Quercetin is an antioxidant flavonoid found in fruits and vegetables such as apples, onions, parsley, cherries, blueberries, and blackberries. It has no distinct traditional herbal preparation history separate from dietary consumption of quercetin-rich plants.
Mucus hypersecretion is a feature of many chronic airway diseases induced by cigarette smoke, and evidence suggests that the antioxidant and anti-inflammatory flavonoid quercetin may protect against cigarette smoke-induced respiratory pathology. The ability of quercetin to protect against cigarette smoke-induced mucin expression has been examined in vivo and in vitro. In vivo, quercetin pretreatment suppressed cigarette smoke-induced goblet cell hyperplasia, inflammation, oxidative stress, EGFR phosphorylation, and NF-κB pathway activation in rat lung. In vitro, quercetin pretreatment attenuated cigarette smoke extract-induced Muc5ac expression, NF-κB activation, and EGFR phosphorylation. These results suggest that quercetin attenuates mucin protein synthesis, possibly by inhibiting oxidative stress and inflammation. This is animal and in vitro evidence only; controlled human trials specifically evaluating quercetin's effect on mucus production are lacking.
Quercetin stabilises mast cells, inhibits Lyn/PLCγ pathways, and improves rhinitis symptoms in small randomised trials using bioavailable formulations. There is some evidence from animal studies that quercetin may reduce mucus secretion for those with chronic lung diseases. Evidence strength: Preclinical and mechanistic; human trial data are limited and small.
Ginger, the rhizome of Zingiber officinale, is used as a spice globally and has a long history of medicinal use. Anti-inflammatory, antioxidant, antitumour, and antiulcer effects of ginger have been proven in many scientific studies, and some ancient applications of ginger as a home remedy have been confirmed in human studies. In Ayurveda and Traditional Chinese Medicine, ginger has long been applied as a warming herb to dispel phlegm and "cold" respiratory conditions. Fresh and dried ginger preparations, including teas and decoctions, are used traditionally for cough, bronchitis, and excess mucus.
Phenolic compounds in ginger include gingerol, paradols, and shogaol, which are proposed to inhibit pro-inflammatory pathways relevant to mucus hypersecretion. Much of the available evidence on ginger in respiratory conditions is preclinical or indirect. Ginger's anti-inflammatory properties are well established mechanistically, but clinical human trials specifically addressing phlegm and mucus are scarce and low in quality. Stronger human evidence exists for ginger's effects on nausea and gastrointestinal symptoms.
High-vitamin-C foods such as citrus fruits, rosehips, and berries have been used across many cultures as cold and respiratory remedies. The connection between scurvy (vitamin C deficiency), mucosal fragility, and susceptibility to infection was recognised empirically before the vitamin itself was identified.
Some nutrients play key roles in maintaining the integrity and function of the immune system, presenting synergistic actions in steps determinant for the immune response. Among these, zinc and vitamins C and D stand out for having immunomodulatory functions and for playing roles in preserving physical tissue barriers. The deficiency or insufficiency of these key nutrients, acting in synergy on tight and adherens junction proteins, can lead to impairment of mucosal epithelial cells, possibly making them more susceptible to pathogen entry.
Vitamins C, D, and E do not reduce the incidence of the common cold in the general population, but vitamin C may reduce incidence by half in people who are exposed to physical and environmental stress. Even though vitamins C and E can shorten the duration and reduce the severity of the disease, it is not considered reasonable to consume them regularly for a minimal reduction in clinical outcomes. The research indicates that vitamin C may have a mitigating effect on viral respiratory infections, whereas a deficiency in vitamin D might heighten susceptibility to COVID-19. Evidence strength: Moderate for reducing duration/severity of upper respiratory infections; weak for directly reducing mucus production per se.
There is no traditional herbal use of vitamin D as an isolated compound; historically, sun exposure and cod-liver oil were used empirically to prevent and treat respiratory illnesses, particularly in northern European folk medicine, without awareness of the specific mechanism.
Vitamin D is involved in a wide range of immunomodulatory activities, helping alleviate lung injury by upregulating angiotensin-converting enzyme 2 (ACE2), decreasing inflammatory cytokines, and increasing antimicrobial peptides. Numerous studies have indicated that administration of these vitamins, particularly to people who are deficient, can decrease the risk and severity of respiratory infections. An intake of 50,000 IU/month of vitamin D showed efficacy in reducing C-reactive protein (CRP) levels across reviewed meta-analyses. Evidence strength: Moderate for reducing risk and severity of respiratory infections in deficient individuals; direct effect on mucus secretion is not well characterised in human trials.
Zinc-containing compounds have a history of use in traditional medicine, but isolated zinc supplementation for respiratory conditions is a modern practice arising from understanding of its role in immune function.
Zinc is able to modulate antiviral and antibacterial immunity as well as regulate the inflammatory response. Zinc supplementation may improve clinical deterioration and the duration of pneumonia in children under five. A dose of 50 mg/day of elemental zinc supplementation showed positive results in CRP reduction across reviewed meta-analyses. Current evidence of efficacy for zinc in preventing or treating colds is considered interesting enough that common cold patients may be encouraged to try zinc, although further studies are needed. Evidence strength: Moderate for reducing common cold duration; effect on mucus production specifically is an indirect outcome.
Cod-liver oil and other fish oils have been used in traditional Northern European and coastal cultures for respiratory and general health. Their use predates the discovery of omega-3 fatty acids as their active components.
Inflammation contributes to lung function decline and the development of chronic obstructive pulmonary disease. Omega-3 fatty acids have anti-inflammatory properties and may benefit lung health. Given the interplay between pro-inflammatory omega-6 fatty acids and the less pro-inflammatory omega-3 fatty acids, it has been theorised that the latter could play a key role in treating or preventing asthma. However, a systematic review of ten RCTs concluded that given the largely inconsistent picture within and across respiratory outcomes, it is impossible to determine whether or not omega-3 fatty acids are an efficacious adjuvant or monotherapy for children or adults with asthma. Evidence strength: Weak to preliminary for directly reducing mucus or phlegm; stronger mechanistic rationale via anti-inflammatory pathways.
Honey has been used in virtually all traditional medicine systems — including Ayurveda, Unani medicine, and European folk medicine — as a remedy for sore throats, coughs, and bronchial complaints. It has been used alone and combined with ginger, black pepper, lemon, or herbs as soothing preparations for productive and dry cough.
Honey has been reported effective in promoting wound healing, facilitating re-epithelialisation, and reducing microbial contamination, which may be attributed to the organic acids, peptides, phenolics, and enzymes it contains. In the context of cough and phlegm, WHO guidelines acknowledge honey as a demulcent that may relieve symptoms of upper respiratory infections in children over 12 months. Evidence specific to mucus reduction is limited, but several studies have examined honey's effect on cough symptoms. Evidence strength: Moderate for symptom relief (cough, throat sore); direct mucolytic or anti-phlegm evidence in controlled human trials is weak.
Licorice root is one of the most widely used herbs in Traditional Chinese Medicine, Ayurveda, and European herbal medicine, where it is classified as an expectorant and demulcent for respiratory complaints. It has been used in tea, decoction, and as a confectionery lozenge for cough and throat irritation.
One study on licorice revealed that licorice pastille significantly decreased Leicester Cough Questionnaire scores in patients with chronic cough. Evidence strength: Very limited; a single small clinical study. Mechanistic data in pre-clinical models is more extensive. Glycyrrhizin, a major active compound, has documented anti-inflammatory activity in cell and animal models. High-dose or prolonged use of licorice is associated with adverse effects including hypertension and hypokalaemia.
It is very important for people with respiratory conditions such as COPD to stay hydrated. Being properly hydrated helps to thin mucus, which makes it easier to cough up. Being dehydrated may make it harder to breathe due to effects on small airway function. Mucus is able to absorb water or dehydrate through pH variations. The swelling capacity of mucus stems from the bottlebrush structure of mucin within which hydrophilic segments provide a large surface area for water absorption. Adequate fluid intake is therefore a fundamental and low-risk measure discussed in authoritative sources for supporting mucus clearance.
The Mediterranean diet is not a strict plan but a flexible approach to healthy eating. The diet features lots of plant-based foods like whole grains, fruits, vegetables, legumes, and healthy fats such as olive oil. The diet emphasises fish and other seafood over other types of meat.
Children at age 6.5 years were less likely to have wheeze, atopic wheeze, and atopy if their mothers had high compliance with a Mediterranean diet during pregnancy. A study aimed to explore the relationship between different dietary patterns and the risk of chronic respiratory diseases including chronic bronchitis, emphysema, and asthma. A total of 23,042 adults from the United States were selected from the NHANES dataset between 2007 and 2018. Diet quality was assessed using 2-day, 24-hour dietary recall data and quantified as the Healthy Eating Index-2020, the Dietary Inflammation Index, the Mediterranean Dietary Index, and the DASH Index.
An array of studies have reported the positive impact of the DII (Dietary Inflammation Index), DASH, and the Mediterranean diet on respiratory health. Western dietary patterns, notably marked by an elevated intake of preserved and processed meats, are correlated with a heightened risk of chronic respiratory diseases. This correlation could be due to the inflammatory consequences of excessive sugar, salt, and nitrite consumption from processed foods.
One cross-sectional study based in Japan found that a diet higher in fast food and quick sugar was associated with an increased prevalence of wheeze (OR: 1.19; 95% CI: 1.04, 1.37). The mechanism proposed in the literature involves activation of pro-inflammatory pathways by high glycaemic diets that can drive cytokine-mediated airway changes.
Smoking and air pollution are important risk factors for COPD. Therefore, smoking cessation and improvement of air quality should be the primary measures to prevent and treat mucus hypersecretion in chronic airway inflammatory diseases.
In chronic disease, factors such as old age, poor diet, disturbances in the microbiome, and exogenous exposures result in poor barrier function and mucus turnover, growth of pathogens, or poorly adapted microbes that reduce diversity in the microbiome, increase Th2, Th17, and pro-inflammatory cytokine responses. These changes contribute to chronic inflammation and the development and progression of disease.
Energy and protein demand are higher in patients with COPD, and insufficient intake leads to respiratory muscle weakness. Some studies reported that protein supplementation in COPD patients improves inflammation, muscle strength, quality of life, and exercise tolerance.
Clinical trial evidence for URTI includes reduction of mucus and airway congestion as documented outcomes. Andrographis is recognized in traditional Chinese medicine for 'clearing heat' from the lungs and resolving phlegm. The WHO's documented clinical indications include bronchitis and sinusitis, conditions characterized by excess mucus production.
Aster root is one of the most pharmacologically studied herbs for expectorant activity. Animal studies with validated phenol red tracheal secretion methodology confirm significant mucus-thinning and expectorant effects, with triterpenoid saponins, caffeoylquinic acids, and aster peptides identified as the active constituents responsible.
Balloon flower (Platycodon grandiflorus) root is a classic TCM expectorant used for phlegm-related coughs, bronchitis, and lung carbuncles. Its saponins—particularly platycodin D—are recognized in TCM pharmacopeias and modern research as exhibiting significant antitussive, expectorant, and anti-inflammatory effects. It is listed among the most commonly adopted expectorant herbs in Chinese clinical respiratory therapy.
Bromelain is a complex of proteolytic enzymes from pineapple (Ananas comosus) with documented mucolytic and anti-inflammatory action on respiratory mucosa. PMC evidence shows it has significant action in dissolving bronchial secretions and acts on sinonasal mucosa. It is used for bronchitis and sinusitis to reduce mucus via proteolytic degradation of mucus glycoproteins.
Cajuput oil's major constituent, 1,8-cineole, has documented expectorant and mucolytic properties with clinical evidence in rhinosinusitis and bronchitis. An ex vivo study (PMC4514714) showed 1,8-cineole significantly reduces mucin-filled goblet cells in LPS-induced nasal tissue. Cajuput oil is listed as an expectorant in pharmacological sources (RxList) and is an ingredient in commercial expectorant inhalant products.
Capsaicin stimulates TRPV1 receptors in the airway, acutely inducing watery mucus secretion to dilute and mobilize viscous phlegm, while repeated low-dose application desensitizes airway TRPV1, reducing neurogenic inflammation and excess mucus over time. Intranasal capsaicin spray preparations are used clinically for non-allergic rhinitis with mucus symptoms.
Alpha-chymotrypsin acts as a mucolytic agent, directly liquefying mucus and decreasing the viscosity of sputum. It has been used clinically via inhalation and instillation for respiratory mucus conditions. A published PMC case report (2021) documents successful endotracheal instillation of alpha-chymotrypsin to dissolve bronchial casts, and its mucolytic clinical use is referenced in peer-reviewed literature.
1,8-Cineole (eucalyptol) is the principal constituent of eucalyptus essential oil with demonstrated mucolytic, expectorant, and anti-inflammatory activity. It inhibits MUC2 and MUC19 mucin gene expression and downregulates NF-κB-mediated inflammatory cascades driving mucus hypersecretion. Clinical studies confirmed significant improvement in asthmatic patients and relief of rhinosinusitis.
Eucalyptus contains 1,8-cineole (eucalyptol), a mucolytic monoterpene with well-documented anti-inflammatory, mucolytic, and bronchodilatory effects. Administration of 1,8-cineole to asthmatic patients significantly improved lung function and alleviated dyspnoea. It is widely used in licensed cough lozenges, inhalants, and vaporizers for mucus clearance.
Fennel (Foeniculum vulgare) seeds and essential oil have traditional and scientific support as expectorants for respiratory mucus. Fennel seeds enhance ciliary motility of the respiratory apparatus, and fennel essential oil inhalation stimulates tracheal smooth muscle contraction, promoting expectoration of mucus and foreign particles. Commission E and ESCOP recognize fennel for catarrh of the upper respiratory tract.
Fritillary is pharmacologically documented as an expectorant. In vivo studies show it increases tracheal secretion and reduces mucin MUC5AC gene expression. It has been China's classic 'phlegm-resolving' herb for over two millennia. Animal studies and pharmacological reviews support this as its most robustly evidenced action.
Ginger (Zingiber officinale) is used traditionally in Ayurveda and TCM as a warming expectorant for cold phlegm and congestion. Its anti-inflammatory and expectorant effects reduce airway irritation and promote mucus clearance. Research demonstrates it acts on immune pathways underlying allergic mucus production. It is listed among natural expectorants by WebMD and Healthline.
Glycyrrhetinic acid is the principal metabolite of glycyrrhizin from licorice root with anti-inflammatory effects relevant to mucus regulation. It inhibits pro-inflammatory cytokines driving goblet cell hyperplasia and mucus hypersecretion. Preclinical data confirm it modulates MUC5AC expression and inflammatory pathways in respiratory tissue, contributing to licorice root's expectorant and anti-mucus effects.
Glycyrrhizin is the primary triterpenoid saponin in licorice root with documented effects on mucus hypersecretion. It attenuated mucus hyperproduction and goblet cell hyperplasia in two murine lung inflammation models via inhibition of MUC5AC gene transcription. It also exhibits antiviral activity against respiratory viruses including RSV, Influenza, and SARS-CoV-related coronaviruses.
Honey has extensive clinical evidence for cough relief and mucus-associated respiratory symptoms. A meta-analysis including 14 RCTs found honey more effective than usual care for cough frequency and severity in upper respiratory tract infections. Mayo Clinic references the Cochrane Database review supporting honey for calming coughs, and it soothes irritated mucous membranes via mechanical coating and antimicrobial effects.
Ivy (Hedera helix) leaves are recognized by the EMA as an expectorant for productive coughs, widening airways and stimulating mucus release. A 2021 observational study of 730 participants confirmed the thyme/ivy combination BNO 1200 reduced cough and improved quality of life. Hedera saponins increase secretion of watery mucus by bronchial cells, and sufficient clinical evidence has been gathered to prove positive effects in cough therapy.
NAC (deacetylated to L-cysteine in vivo) is one of the most widely used mucolytic agents globally, licensed in numerous countries for reducing mucus viscosity. It depolymerizes mucoproteic complexes and breaks disulfide bonds in mucins, facilitating expectoration. A 2024 systematic review confirmed its effects on mucus hypersecretion in COPD.
L-cystine is a metabolic precursor to cysteine, which underlies the mucolytic mechanism of N-acetylcysteine (NAC). The free sulfhydryl group of cysteine cleaves disulfide bonds in mucoproteins, reducing mucus viscosity. This biochemical action is well-established, with NAC—the primary pharmaceutical cysteine delivery form—having regulatory approval for mucolytic use in multiple countries.
Licorice root (Glycyrrhiza spp.) is a traditional TCM expectorant used for cough, sore throat, asthma, and bronchitis. Glycyrrhizin attenuates mucus hyperproduction and goblet cell hyperplasia in murine lung inflammation models. A 2018 study identified antitussive and expectorant activities in 14 major licorice compounds. An RCT in 36 chronic asthma patients showed licorice improved pulmonary function similarly to prednisolone.
Malabar nut (Adhatoda vasica) has extensive traditional use in Ayurvedic and Unani medicine for respiratory ailments. Its primary alkaloid vasicine exhibits bronchodilatory, expectorant, and anti-inflammatory properties so potent it was the basis for synthesizing bromhexine and ambroxol. Multiple preclinical studies demonstrate it relaxes tracheal muscles, reduces bronchospasm, and helps clear mucus from the respiratory tract.
Marshmallow root (Althaea officinalis) is a traditional demulcent used for centuries for soothing coughs and mucous membranes. A 2020 in vitro study confirmed its coating effect and antioxidative and anti-inflammatory properties. An herbal cough syrup containing marshmallow root showed 90% participant satisfaction after 12 days. ESCOP and Commission E recognize its use for dry, irritating cough and catarrh.
Menthol oil is the concentrated form of l-menthol from peppermint, widely used in pharmaceutical preparations for mucus and respiratory congestion. Animal model data demonstrate up to 44% increase in tracheobronchial secretion following application. It modulates the cough reflex and is incorporated in numerous licensed OTC preparations for mucus clearance worldwide.
Mucins are the primary macromolecular components responsible for the viscoelastic and gel-forming properties of mucus throughout the body, including airways and the gastrointestinal tract. Aberrant mucin secretion and accumulation are clinical hallmarks of chronic respiratory diseases including COPD, asthma, and cystic fibrosis. Regulation of mucin gene expression is a major research and therapeutic target.
Mullein (Verbascum thapsus) has been used in European folk medicine for centuries for bronchitis, dry coughs, and respiratory discomfort. Its saponins promote expectorant activity, while its mucilages coat and soothe irritated mucous membranes. Scientific evidence is primarily preclinical and traditional, with anti-inflammatory and antioxidant properties supporting its use in thinning mucus.
NAC is a well-established mucolytic that hydrolyzes disulfide bonds in mucin, reducing mucus viscosity and facilitating airway clearance. A 2024 systematic review confirmed significant inhibitory effects on MUC5AC and MUC5B gene and protein expression, and reduction of goblet cell hyperplasia. A large multicenter RCT (n=333) demonstrated IV NAC superior to placebo for improving sputum viscosity and expectoration difficulty in hospitalized patients with respiratory disease.
Peppermint contains menthol, which acts as a decongestant and expectorant that thins mucus and loosens phlegm. ESCOP therapeutic indications for peppermint include catarrhs of the upper respiratory tract. Menthol-based preparations show up to 44% increase in tracheobronchial secretion in animal models. Peppermint is listed among established natural expectorants by WebMD and Healthline.
Bromelain exerts mucolytic effects, reducing mucus viscosity and volume in the respiratory tract. Clinical data in sinusitis populations document improved mucus drainage. Bromelain has been included in traditional and modern formulas for cough and chest congestion.
Plantago contains mucilage polysaccharides and expectorant constituents that act on mucous membranes to reduce excessive mucus production and facilitate expectoration. Clinical improvements in sputum production were observed in the P. major acute bronchitis RCT. Plantago lanceolata is recognized as an expectorant in official monographs.
Platycodon's expectorant and mucolytic properties are among its most pharmacologically confirmed effects. Platycodin saponins enhance tracheal mucociliary movement and stimulate respiratory secretions that aid phlegm clearance. This effect is recognized in the Chinese Pharmacopoeia and supported by modern pharmacological evidence.
Platycodon root (from Platycodon grandiflorus) is the dried root of balloon flower widely used in TCM for expelling phlegm and treating respiratory catarrh. Modern pharmacological studies confirm significant antitussive, expectorant, and anti-inflammatory effects mediated by its saponins. Jiegeng saponins enhance expectorant effects through gut microbiota metabolism and regulation of arachidonic acid metabolism.
P. tenuifolia triterpenoid saponins promote phlegm clearance via a reflex expectorant mechanism through mild gastric mucosal stimulation and enhanced bronchial secretion via vagal pathways. It is listed in the Chinese Pharmacopoeia as a mucolytic expectorant, and preclinical studies confirm antitussive and phlegm-reducing activity.
Serratiopeptidase acts as a mucolytic by breaking down the protein substructures of mucus, reducing its viscosity and making it easier to expectorate. Clinical trials in chronic sinusitis and chronic airway disease demonstrate significant reductions in mucus viscosity and sputum weight. It is one of the most consistently supported applications across the clinical literature.
Aster tataricus is one of the most rigorously documented herbal expectorants in Chinese Pharmacopoeia. The triterpenoid shionone and flavonoids luteolin and quercetin are confirmed as active expectorant compounds in preclinical models. A 2015 pharmacological study confirmed expectorant activity in phenol red secretion tests in mice. The mechanism involves thinning mucus secretions via saponin action on bronchial mucosa.
Thyme (Thymus vulgaris) is one of the best-studied herbs for respiratory mucus, acting as both an expectorant and mucolytic through thymol and carvacrol. A 2021 RCT with 730 participants demonstrated a thyme/ivy combination syrup significantly reduced acute cough and cough severity. ESCOP indications include catarrh of the upper and lower respiratory tract.
Thymol directly exerts secretolytic effects on cells of the respiratory tract, increasing mucus fluidity and facilitating phlegm clearance. This mechanism is supported by in vitro data and forms the pharmacological basis for thyme's use in productive cough. Clinical trials confirm thyme preparations reduce cough severity in conditions with excess mucus and phlegm.
Turmeric (Curcuma longa) and its primary compound curcumin have been validated in various studies as expectorants and potential bronchodilators with effects on respiratory and immune health. Animal studies show curcumin attenuates mucus hypersecretion in asthma models. Traditional Ayurvedic use of turmeric for mucus-associated cough and bronchial congestion is well-documented.
Vasicine is an alkaloid from Adhatoda vasica (Malabar nut) with demonstrated bronchodilatory, expectorant, and anti-inflammatory properties so potent it was the basis for synthesizing the pharmaceutical mucolytics bromhexine and ambroxol. In vitro and animal studies show it relaxes tracheal muscles, increases bronchial secretions, and facilitates phlegm expulsion.
Vasicinone is a quinazoline alkaloid from Adhatoda vasica that shows synergistic bronchodilatory and expectorant effects with vasicine. Studies indicate it enhances vasicine's therapeutic efficacy in respiratory applications, contributing to increased bronchial secretion and mucus clearance. Preclinical evidence supports its role in the combined expectorant activity of Adhatoda vasica.
A. spectabilis leaves are characterized as expectorant in traditional Nepalese and Indian medicine, indicating use for clearing mucus and phlegm from the respiratory tract. The leaves are described as mucolytic and antitussive in Himalayan folk medicine traditions.
Ajwain is traditionally classified as an expectorant and 'kaphahara' (mucus-reducing) herb in Ayurveda and Unani medicine. Steam inhalation with ajwain is a widely used home remedy for chest congestion. Preclinical bronchodilatory data provide mechanistic support, but human expectorant studies are absent.
Anise (Pimpinella anisum) seed and its essential oil are traditional expectorants used across European, Asian, and Middle Eastern medicine for cough and mucus clearance. German Commission E approved anise for catarrh of the upper respiratory tract. Its primary active compound trans-anethole contributes expectorant properties. EBSCO Research Starters and ESCOP list anise essential oil among treatments for mucus-related respiratory conditions.
Apricot kernel (xing ren) is classified in TCM as an expectorant that promotes mucus clearance from the respiratory tract. It is described as 'moistening the lungs' and is used for both dry and productive coughs with phlegm. This expectorant use is among the oldest and most consistently cited applications of the herb across Chinese medical texts.
Arisaema is a classic TCM phlegm-resolving herb used for centuries for respiratory mucus, phlegm accumulation, and wet coughs. A Spandidos clinical review explicitly names it as one of the most commonly adopted expectorant herbs in Chinese clinical respiratory therapy. TCM classifies it as a warm-natured, phlegm-drying herb whose triterpenoid saponins confer expectorant activity.
Bamboo preparations—particularly Succus Bambusae (bamboo juice), bamboo shavings (zhuru), and tabasheer (tianzhuhuang)—have been used for over 2,500 years in TCM to clear phlegm and reduce mucus in respiratory conditions. These uses are extensively documented in classical TCM texts and are still used clinically in Chinese medicine.
Bayberry is traditionally classified as an astringent that 'tones' excessively wet or congested mucous membranes, reducing mucus secretion in the respiratory and gastrointestinal tracts. It has been used to bring tone to mucous membranes in conditions involving excess phlegm. This is a traditional use without clinical trial evidence.
Belleric myrobalan is a core traditional remedy for excess mucus and phlegm in Ayurveda, specifically classified as beneficial for Kapha-type conditions associated with mucus accumulation. Gaia Herbs documents its alterative properties promoting normal secretions in the lungs. Classical texts and ethnobotanical records across South and Southeast Asia describe it for hoarseness of voice, cough with phlegm, and bronchial congestion.
Black pepper is used in Ayurveda, TCM, and Western herbal traditions as an expectorant and mucolytic for sticky, excess mucus and phlegm. The Trikatu formula specifically addresses lung problems accompanied by sticky mucus. Piperine's irritant and thermogenic actions on respiratory mucosa are proposed mechanisms.
Black seed (Nigella sativa) has traditional use in Islamic medicine and Ayurveda for respiratory conditions including cough and phlegm. Thymoquinone, its primary bioactive, exhibits anti-inflammatory and bronchodilatory effects in preclinical studies. It is listed among expectorant herbs in traditional medicine references for mucus-producing coughs and congestion.
Black spruce essential oil is traditionally used as an expectorant and mucolytic to clear mucus and phlegm. Its camphene content is specifically noted as a mucolytic agent. Aromatherapy references widely document this use for catarrh and congestion.
Boneset is traditionally classed as a mild expectorant that helps loosen and clear mucus from the respiratory tract. This expectorant action is noted across multiple historical sources including Lockwood (1847) and modern herbalist references. It is commonly used as a hot infusion to promote expectoration during colds, flu, and bronchitis. No clinical trials exist specifically assessing its expectorant effect.
Butterbur has historical use as a remedy for cough and respiratory mucus, with P. japonicus used as an expectorant in traditional Japanese and Taiwanese medicine. The German Commission E assessed the leaf for cough but gave a negative rating, preferring other herbs. No modern RCT evidence addresses this indication.
Camphor is widely used in traditional and folk medicine—and in OTC chest rubs—to loosen mucus and phlegm via inhalation or topical application. FDA DailyMed lists camphor-containing products for temporary chest congestion relief. The mechanism involves aromatic vapor interaction with mucosal receptors, but evidence for direct mucolytic efficacy is limited.
Capsicum (chili pepper) is used traditionally in Ayurveda, TCM, and folk medicine as a warming expectorant for cold, white phlegm and respiratory congestion. Capsaicin, its active compound, stimulates TRPV1 receptors inducing watery mucus secretion to thin viscous phlegm. It appears in multiple traditional expectorant herb lists across Ayurvedic, TCM, and Western herbal references.
Caraway is traditionally classified as an expectorant in European and Ayurvedic herbal systems, used to loosen phlegm and clear the respiratory tract. Traditional monographs and herbal references list it as a cough remedy and demulcent in bronchopulmonary disorders. No human clinical trials exist for this specific indication.
Cardamom is used traditionally as an expectorant in Ayurvedic, Unani, and South Asian medicine for excessive mucus and phlegm, helping to loosen and clear respiratory secretions. The volatile oil component 1,8-cineole (also a component of eucalyptol) is a known expectorant with mucolytic properties that provides pharmacological plausibility.
Cayenne pepper has a well-documented traditional use as a mucolytic and expectorant, stimulating the release of mucus from the respiratory passages and aiding its clearance. This is attributed to capsaicin's irritant action on the respiratory mucosa, which triggers secretory reflexes. Clinical RCT evidence specific to mucus clearance is lacking.
A. aspera is described as antiphlegmatic and expectorant in Ayurvedic and Siddha traditions. Its saponins carry expectorant properties, and it has been used for cough, cold, and phlegm. Preclinical bronchodilator evidence provides partial scientific support.
Chen Pi (dried tangerine/citrus peel, Citrus reticulata) is a key TCM herb used to transform phlegm, dry dampness, and regulate qi in respiratory conditions. Laboratory studies indicate volatile oils and flavonoids in Chen Pi have anti-inflammatory, antitussive, and expectorant effects. Animal studies show Chen Pi extracts can reduce cough and modulate mucus production, though robust human clinical RCTs are lacking.
Chickweed is classified as an expectorant herb in traditional medicine, with saponins credited for loosening and expelling mucus from the respiratory tract. It is used for coughs with sticky or dry phlegm. No clinical trials have been performed for this use.
Clove and eugenol have longstanding traditional use as expectorants to clear mucus and phlegm in respiratory conditions. PMC pharmacological reviews document expectorant and decongestant properties of clove essential oil.
Coltsfoot (Tussilago farfara) has been used for centuries in traditional herbal medicine for bronchitis, whooping cough, and phlegm. A pharmacological study identified antitussive, expectorant, and anti-inflammatory activities from caffeoylquinic acids. It is classified as a relaxing or soothing expectorant in naturopathic herbal pharmacopeias for mucus-related coughs.
E. purpurea has traditional use for nasopharyngeal catarrh and conditions involving excess mucus as part of upper respiratory tract infections. The German Commission E, WHO, and ESCOP monographs list respiratory catarrh among the traditional indications. Clinical trials have not isolated mucus reduction as a specific outcome measure.
Elecampane (Inula helenium) root is a well-established traditional expectorant with mucolytic properties that thin and clear phlegm from the lungs. Used by Native Americans and in Western herbalism for lung diseases including bronchitis. Its sesquiterpene lactones possess antimicrobial and expectorant properties, and multiple herbal pharmacopeias describe it as an effective mucolytic expectorant.
Elderflower is traditionally used in European herbal medicine to address excess mucus and catarrh associated with colds and flu. The EMA monograph recognizes elderflower for upper respiratory symptoms including mucous discharge. No clinical trials have specifically targeted mucus or phlegm as a primary endpoint.
Fenugreek (Trigonella foenum-graecum) is a traditional Ayurvedic and Middle Eastern expectorant valued for loosening phlegm and soothing inflamed airways. Its high mucilage content creates a soothing coating effect and stimulates mucus secretion to thin viscous respiratory secretions. Naturopathic pharmacopeias classify it as a soothing expectorant for productive coughs.
Asafoetida is consistently described as an expectorant in traditional herbalism, including European, Ayurvedic, Unani, and Middle Eastern medicine. The volatile oil of the resin is eliminated through the lungs, directly acting on bronchial secretions to loosen and expel mucus and phlegm.
The Chinese Pharmacopoeia lists Fu Ling for 'phlegm' and 'productive cough,' and classical TCM texts describe it as resolving 'dampness and phlegm' accumulation. It is used in formulas such as Er Chen Tang for phlegm-related conditions. Scientific evidence for this specific indication is limited to its traditional context.
Garlic (Allium sativum) contains allicin and organosulfur compounds traditionally used as expectorants and antimicrobials for cough and mucus clearance across multiple medicine systems. WebMD lists garlic among natural expectorants. Its volatile organosulfur compounds are secreted via the lungs, helping thin mucus and stimulate mucociliary clearance.
Garlic has been used in traditional medicine across multiple cultures for clearing mucus and phlegm, particularly in respiratory infections. Garlic's antimicrobial properties reduce the infectious burden that drives excess mucus production. Traditional Chinese and Ayurvedic medicine document this application. No modern RCT has evaluated garlic for mucus reduction as a primary endpoint.
Resolving phlegm and acting as an expectorant are core traditional indications for G. littoralis in TCM, Mongolian, and Korean herbal medicine. TCM prescriptions containing G. littoralis are explicitly described for 'resolving phlegm.' Pharmacological antitussive activity provides partial scientific support, but specific mucolytic/expectorant mechanisms have not been studied in controlled trials.
Goldenrod is traditionally classified as an anticatarrhal herb — one that reduces excessive mucus production in both the upper respiratory and urinary tracts. This property is documented in European and North American traditional herbal medicine. It is recognized as a 'mucous membrane trophorestorative' in professional herbal practice. No clinical trials have assessed this specific action.
Goldenseal is traditionally regarded as a specific tonic for inflamed mucous membranes throughout the body, including the respiratory tract, where it is used to reduce excess mucus secretion. Its astringent alkaloids are thought to tone and dry secretory membranes. No human clinical trials specifically confirm this effect.
GMT has been traditionally used as an expectorant and antitussive preparation throughout the Balkan region. Traditional use includes combating bronchitis and lung emphysema as a 'loosening agent,' and the hot steam of the infusion is recognized as aiding mucociliary clearance. No clinical trials have specifically quantified its expectorant effect in humans.
H. spicatum is traditionally classified as an expectorant in Ayurvedic and folk medicine, used to facilitate clearance of mucus and phlegm from the respiratory tract. It is listed in traditional indications as an expectorant, and is included in Ayurvedic formulations targeting respiratory secretions.
Horehound (Marrubium vulgare) is a member of the mint family with a long history in Western herbalism for dry, spasmodic, non-productive coughs and bronchitis. It is classified as a stimulating expectorant and is one of the ingredients in Ricola herbal cough drops. German Commission E recognizes its traditional use and multiple pharmacopeias include it as an expectorant for mucus-related coughs.
Horseradish (Armoracia rusticana) root has a long tradition as a warming, stimulating expectorant for sinusitis, bronchitis, and mucus-laden respiratory conditions. Its primary active compound allyl isothiocyanate (released on crushing) stimulates mucus flow and promotes respiratory drainage. German Commission E recognized horseradish for supportive treatment of catarrh.
Traditional Chinese and Ayurvedic medicine document use of hyacinth bean for phlegmatic disorders. It is classified in TCM as resolving dampness, which encompasses excessive phlegm and mucus-related conditions. Multiple ethnobotanical sources and PMC-indexed reviews confirm use for phlegmatic diseases.
Hyssop (Hyssopus officinalis) has been used medicinally for millennia as a warming, stimulating expectorant for respiratory conditions with phlegm. German Commission E approved hyssop for catarrh of the upper respiratory tract. Naturopathic pharmacopeias classify it as a stimulating expectorant alongside elecampane and lobelia for thick, cold mucus.
Traditional Ayurvedic use of Boswellia for cough, bronchitis, and asthma encompasses reduction of excessive mucus production. 5-LOX inhibition reduces leukotriene-driven mucus hypersecretion in airways. The Gupta et al. (1998) asthma RCT reported resolution of dyspnoea and abnormal lung sounds (rhonchi), indirectly reflecting reduced airway secretions.
I. racemosa is classified as an expectorant in Ayurvedic classical texts including the Charaka Samhita, where it is indicated for kasa (cough) and swasa (breathlessness) with kapha (phlegm) accumulation. Its kapha-reducing and expectorant properties are a core traditional application across Ayurvedic, Chinese, and Himalayan ethnomedicinal traditions.
Lily bulb is traditionally used across Asian and Indian medical systems as an expectorant and for clearing phlegm. In TCM it is specifically noted for 'blood-tinged sputum'. In India, the bulb is used as an expectorant. Saponins provide a pharmacologically plausible expectorant mechanism. No human clinical trials for mucus/phlegm specifically have been conducted.
Lobelia (Lobelia inflata) is a potent traditional bronchodilator and stimulating expectorant used in Native American and Western herbalism for asthma, bronchitis, and mucus clearance. Lobeline, its primary alkaloid, acts as a bronchial stimulant and expectorant helping to clear mucus and ease breathing. Naturopathic pharmacopeias and IntechOpen respiratory reviews confirm its expectorant role.
Lungwort (Pulmonaria officinalis) has traditionally been used as an expectorant and anti-inflammatory herb for respiratory issues including phlegm and breathing difficulties. In modern herbal medicine it is still used for cough and cold remedies, believed to loosen phlegm and mitigate breathing issues. Its use is recognized in multiple herbal pharmacopeias for respiratory mucus conditions.
Marjoram is classified as an expectorant in herbal medicine and has been used traditionally to help clear mucus and phlegm from the respiratory tract. This is documented across multiple folk medicine traditions.
Milkweed, particularly A. tuberosa, has a well-established traditional role as an expectorant—promoting the loosening and expulsion of mucus from the respiratory tract. This was one of its core properties in both Indigenous North American medicine and 19th-century Eclectic pharmacy. It was described as promoting 'suppressed expectoration.' No clinical evidence exists for this effect.
Peppermint and menthol have a long tradition of use as expectorants to loosen mucus and ease coughs across European and Asian herbal medicine systems. The German Commission E approved peppermint oil for internal use including catarrhs of the respiratory tract. Direct human clinical trial evidence for this specific indication is limited.
In Traditional Chinese Medicine, monk fruit is classified as a phlegm-transforming, lung-moistening herb used to relieve productive cough and reduce phlegm accumulation. Multiple botanical reviews and TCM monographs document this use. No human clinical trials specifically testing monk fruit's mucolytic or expectorant activity have been published.
Mustard is documented in herbal monographs as a mucolytic: its volatile oils thin and loosen mucus in the respiratory tract. The Herbal Reality mustard monograph specifically cites this mechanism. Applied as a chest pack, mustard is traditionally used to facilitate phlegm expulsion during respiratory infections.
Myrrh is classified as an expectorant in multiple herbal traditions and pharmacopoeias, used to help clear mucus and phlegm from the respiratory tract. Its essential oil is added to vaporizers and used as a chest rub for bronchial congestion. No clinical trials specifically evaluating expectorant efficacy exist.
In TCM, Ophiopogon japonicus is classified as a yin-nourishing, lung-moistening herb used to treat dry cough with thick or sticky sputum. It is described as stimulating mucus production to make coughs more productive. The Mai Men Dong Tang formula relies on the herb specifically for this indication.
Classical TCM materia medica and the Chinese Pharmacopoeia describe ophiopogon root as treating dry cough with difficult-to-clear phlegm. Its 'moistening' action is thought to thin and facilitate expectoration of viscous mucus in lung yin deficiency patterns. This is a well-established traditional indication with millennia of documented use.
Orange peel is a primary herb in traditional Chinese medicine specifically for resolving phlegm and reducing mucus production, classified as a 'phlegm-resolving' herb. This use is also documented in Ayurvedic and European herbal traditions. Modern pharmacological evidence for mucolytic activity of orange compounds is plausible but not confirmed in clinical RCTs.
Oregano has extensive traditional use as an expectorant and mucolytic in multiple traditional medicine systems, including Turkish, Iranian, and Greek traditions. Warm oregano infusions or steam inhalations were used to loosen and expel phlegm from the respiratory tract. No clinical human studies have specifically evaluated oregano for mucus reduction.
P. orientalis leaves are classified in TCM and in the Chinese Pharmacopoeia as an antitussive and expectorant, specifically indicated for excessive mucus secretion and phlegm. This is one of the herb's primary traditional respiratory indications, documented in multiple materia medica texts from 934 AD onwards.
Peach leaf is classified as expectorant in multiple traditional medicine systems, and the kernel is described as antitussive and entering the Lung channel in TCM. Peach blossom is used in TCM for 'phlegm retention.' No clinical trials exist.
In TCM, pear is a primary food medicine for phlegm-related conditions including productive cough and chest congestion. It is believed to help the body expel excess mucus and promote clear breathing. Different preparations are tailored to phlegm type (clear, yellow). Scientific mechanistic evidence remains limited to in vitro studies of pear's anti-inflammatory effects on respiratory mucosa.
Pennycress is classified as an expectorant in traditional herbal systems and was used to help clear mucus and phlegm from the respiratory tract. The seeds in Tibetan medicine addressed conditions involving pus in the lungs. This use is consistent with the irritant glucosinolate chemistry shared by mustard-family plants.
Perilla seed (su zi) is a classical TCM herb specifically indicated for excessive phlegm, dyspnea, and asthmatic cough. A 2025 cell study of perilla leaf varieties found significant reductions in MUC5AC (mucus secretion factor) in PM2.5-exposed human nasal cells. Traditional use is well-documented across multiple Asian medical systems.
Plantago lanceolata is endorsed by the Commission E and ESCOP for catarrh of the airways, implying expectorant and mucus-normalizing effects. Mucilage polysaccharides are thought to modulate mucus viscosity and support mucociliary clearance. Traditional use across Europe and Asia for phlegm and productive cough is extensively documented.
Polygala root is formally listed in the Chinese Pharmacopoeia as an expectorant and phlegm-resolving herb. It is one of the primary traditional uses in TCM, with saponins identified as responsible for expectorant activity. Animal studies validate phlegm-expelling effects.
Poppy flower preparations have traditional use as expectorants to clear mucus and phlegm. Kew Gardens' ethnobotanical records describe P. rhoeas as an expectorant for catarrh, and traditional syrups prepared from both species were used to loosen chest congestion.
Traditional Andean and Chilean folk use of Quillaja bark centers on its expectorant action, attributed to the ability of its saponins to promote a more fluid mucus in the airways. This facilitates clearance of phlegm through coughing. The mechanism is plausible given the surfactant nature of the saponins, but no clinical trials have validated this specific endpoint.
In TCM, radish seed (Lai Fu Zi, Raphani Semen) is pharmacopoeially listed for dissipating phlegm and treating cough with phlegm congestion. Ayurveda and European folk medicine similarly use radish as an expectorant and mucolytic. No clinical human trials have confirmed this effect.
Red clover is traditionally classified as an expectorant herb, promoting the clearance of mucus from the respiratory tract. Multiple traditional herbal medicine systems used it to thin mucus and stimulate expectoration from the bronchi. No clinical trial evidence exists for this specific use.
Red root is classified as an expectorant and mucolytic in both Eclectic and modern herbal literature, with traditional use for excessive mucus and phlegm in the respiratory tract. Its saponin content is the proposed mucolytic mechanism, and its astringency is used to reduce hypersecretion. No controlled human studies have been published.
In traditional herbal medicine, sheep's sorrel's astringent tannins were used to dry up excessive mucus secretions in the respiratory and digestive tracts. This is recorded in folk practice and connected to its broader astringent properties. No clinical evidence exists.
Slippery elm (Ulmus rubra) bark contains mucilage that coats and soothes the throat and respiratory tract, and was traditionally used by Native Americans for treating coughs and respiratory conditions. Western herbalism classifies it as a demulcent expectorant for sticky, irritating mucus. Evidence is primarily traditional; it appears in multiple herbal pharmacopeias for respiratory mucous membrane support.
Slippery elm bark (inner bark of Ulmus rubra) contains polysaccharide mucilage that coats and soothes the throat and respiratory tract, traditionally used by Native Americans for cough and respiratory conditions. Western herbalism classifies it as a demulcent expectorant for sticky, irritating mucus and unproductive cough. Evidence is primarily traditional with recognition in naturopathic and herbal pharmacopeias.
Spruce shoots and needle oil contain volatile terpenes with mucolytic activity, particularly camphene and bornyl acetate, which help thin and clear mucus. This underpins their traditional use in cough syrups and inhalations for catarrhal conditions. Spruce needle oil is included in European OTC preparations specifically for this purpose.
Sunflower seeds and leaves are documented expectorants in traditional herbal medicine across multiple cultures. Leaf syrups and seed decoctions were used to clear respiratory mucus and phlegm. This use appears in both Western herbalism (A Modern Herbal) and curanderismo traditions.
Vacha is classified as an expectorant and mucolytic across Ayurveda, Unani, and Chinese traditional medicine. It is listed as sirovirectana (cleansing nasal therapy) in Charaka Samhita. The aromatic volatile oils are proposed to thin and expel phlegm from the respiratory tract.
Trichosanthes fruit is one of the principal TCM herbs for 'transforming phlegm-heat' and is classified as an expectorant in the Chinese Pharmacopoeia. Its seeds are documented as expectorants in Korean classical medicine (Donguibogam), and pharmacological studies confirm expectorant activity in the plant's extracts. No controlled human clinical trials exist for phlegm-specific endpoints.
Tylophora has been traditionally used as an expectorant in Ayurvedic and folk medicine, and historically served as a substitute for ipecacuanha as an expectorant and emetic in the Bengal Pharmacopoeia (1884). Traditionally it is employed to clear mucus and phlegm from the respiratory tract in conditions such as cough and bronchitis.
Vasicinol is a reduced form of vasicine from Adhatoda vasica, a plant with a long history in Ayurvedic and Unani medicine as a bronchodilator and expectorant. It contributes to the bronchodilatory and secretolytic effects of the parent plant's alkaloid complex. Evidence is primarily derived from preclinical studies of the Adhatoda alkaloid mixture.
X. strumarium is used in TCM as a wind-cold herb that opens nasal passages and reduces mucus production in rhinitis and sinusitis. Antitussive (cough-suppressing) activity is documented in multiple pharmacognosy reviews. These properties historically position it as a mucus-regulating herb across respiratory complaints.
The aerial parts of yarrow are traditionally used for phlegm conditions and as an expectorant in European, Persian, and Chinese herbalism. Its essential oil contains 1,8-cineole, a documented mucolytic, and the herb is traditionally combined with elderflower and peppermint for respiratory congestion.
Yellow Root is classified in folk and Appalachian herbalism as having astringent, drying properties that reduce mucus and phlegm. It has been used traditionally for congestion and to soothe mucous membranes. No clinical trials on this specific indication have been identified.
Go back